Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer
PHASE3
This is a Phase III, randomized, double-blind, parallel, multi-center trail...
Status
Active Not Recruiting
Location
Cancer Hospital Chinese Academy of Medical Science
To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer
PHASE3
A randomized, double-blind, parallel-controlled, multicenter trial design w...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Bengbu Medical College